Predictors of sentinel lymph node metastasis in patients with thin melanoma: An international multi-institutional collaboration

Walker, Richard J. B., Hong, Nicole J. Look, Moncrieff, Marc, van Akkooi, Alexander C. J., Jost, Evan, Nessim, Carolyn, van Houdt, Winan J., Stahlie, Emma H. A., Seo, Chanhee, Quan, May Lynn, McKinnon, J. Gregory, Wright, Frances C. and Mavros, Michail N. (2022) Predictors of sentinel lymph node metastasis in patients with thin melanoma: An international multi-institutional collaboration. Annals of Surgical Oncology, 29 (11). 7010–7017. ISSN 1068-9265

Full text not available from this repository. (Request a copy)

Abstract

Background: Consideration of sentinel lymph node biopsy (SLNB) is recommended for patients with T1b melanomas and T1a melanomas with high-risk features; however, the proportion of patients with actionable results is low. We aimed to identify factors predicting SLNB positivity in T1 melanomas by examining a multi-institutional international population. Methods: Data were extracted on patients with T1 cutaneous melanoma who underwent SLNB between 2005 and 2018 at five tertiary centers in Europe and Canada. Univariable and multivariable logistic regression analyses were performed to identify predictors of SLNB positivity. Results: Overall, 676 patients were analyzed. Most patients had one or more high-risk features: Breslow thickness 0.8–1 mm in 78.1% of patients, ulceration in 8.3%, mitotic rate > 1/mm2 in 42.5%, Clark’s level ≥ 4 in 34.3%, lymphovascular invasion in 1.4%, nodular histology in 2.9%, and absence of tumor-infiltrating lymphocytes in 14.4%. Fifty-three patients (7.8%) had a positive SLNB. Breslow thickness and mitotic rate independently predicted SLNB positivity. The odds of positive SLNB increased by 50% for each 0.1 mm increase in thickness past 0.7 mm (95% confidence interval [CI] 1.05–2.13) and by 22% for each mitosis per mm2 (95% CI 1.06–1.41). Patients who had one excised node (vs. two or more) were three times less likely to have a positive SLNB (3.6% vs. 9.6%; odds ratio 2.9 [1.3–7.7]). Conclusions: Our international multi-institutional data confirm that Breslow thickness and mitotic rate independently predict SLNB positivity in patients with T1 melanoma. Even within this highly selected population, the number needed to diagnose is 13:1 (7.8%), indicating that more work is required to identify additional predictors of sentinel node positivity.

Item Type:	Article
Uncontrolled Keywords:	surgery,oncology ,/dk/atira/pure/subjectarea/asjc/2700/2746
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:	http://www.scopus.com/inward/record.url?...
Depositing User:	LivePure Connector
Date Deposited:	13 Oct 2022 10:38
Last Modified:	22 Oct 2022 18:34
URI:	https://ueaeprints.uea.ac.uk/id/eprint/89032
DOI:	10.1245/s10434-022-11936-z

Actions (login required)

View Item